Stefanie Sarantopoulos

5.1k total citations · 1 hit paper
97 papers, 2.7k citations indexed

About

Stefanie Sarantopoulos is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Stefanie Sarantopoulos has authored 97 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 48 papers in Immunology and 20 papers in Oncology. Recurrent topics in Stefanie Sarantopoulos's work include Hematopoietic Stem Cell Transplantation (52 papers), T-cell and B-cell Immunology (38 papers) and Immune Cell Function and Interaction (25 papers). Stefanie Sarantopoulos is often cited by papers focused on Hematopoietic Stem Cell Transplantation (52 papers), T-cell and B-cell Immunology (38 papers) and Immune Cell Function and Interaction (25 papers). Stefanie Sarantopoulos collaborates with scholars based in United States, Canada and United Kingdom. Stefanie Sarantopoulos's co-authors include Jerome Ritz, Bruce R. Blazar, Corey Cutler, Robert J. Soiffer, Joseph H. Antin, Haesook T. Kim, Nazmim S. Bhuiya, Kristen E. Stevenson, Keith M. Sullivan and Harvey Cantor and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Stefanie Sarantopoulos

93 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

2016 283 citations Kenneth R. Cooke, Leo Luznik et al. Biology of Blood and Marrow Transplantation profile →

Peers

Countries citing papers authored by Stefanie Sarantopoulos

Since Specialization

Citations

This map shows the geographic impact of Stefanie Sarantopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Sarantopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Sarantopoulos more than expected).

Fields of papers citing papers by Stefanie Sarantopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Sarantopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Sarantopoulos. The network helps show where Stefanie Sarantopoulos may publish in the future.

Co-authorship network of co-authors of Stefanie Sarantopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Sarantopoulos. A scholar is included among the top collaborators of Stefanie Sarantopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Sarantopoulos. Stefanie Sarantopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation 2024 ·Nature Communications ·Sonia J. Laurie, (unknown), Danny Bruce, Hemamalini Bommiasamy, (unknown), Mostafa Yazdimamaghani, Samantha G. Pattenden, Nelson J. Chao, Stefanie Sarantopoulos, Joel S. Parker, Ian J. Davis, Jonathan S. Serody	4
2	Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis 2023 ·JCO Oncology Practice ·S. M. Qasim Hussaini, Yi Ren, Alessandro Racioppi, M. Lew, Lauren Bohannon, (unknown), Yan Li, (unknown), (unknown), (unknown), Taewoong Choi, Richard D. Lopez, Stefanie Sarantopoulos, Cristina Gasparetto, Gwynn D. Long, Mitchell E. Horwitz, Nelson J. Chao, S. Yousuf Zafar, Anthony D. Sung	8
3	Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials 2023 ·Clinical Cancer Research ·Eduardo Rodríguez‐Arbolí, Catherine J. Lee, Teresa Caballero‐Velázquez, Carmen Martı́nez, (unknown), (unknown), (unknown), Lucía López‐Corral, (unknown), Lynn Onstad, Mitchell E. Horwitz, Stefanie Sarantopoulos, Stephanie J. Lee, Josè Antonio Pérez-Simón	3
4	Financial toxicity and quality of life in patients undergoing bone marrow transplant evaluation: A single center analysis. 2023 ·Journal of Clinical Oncology ·S. M. Qasim Hussaini, Yi Ren, Alessandro Racioppi, M. Lew, Lauren Bohannon, (unknown), (unknown), (unknown), (unknown), Taewoong Choi, Richard D. Lopez, Stefanie Sarantopoulos, Cristina Gasparetto, Gwynn D. Long, Mitchell E. Horwitz, Nelson J. Chao, S. Yousuf Zafar, Anthony D. Sung	1
5	Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD 2022 ·Blood Advances ·Nataliya P. Buxbaum, Gèrard Socié, Geoffrey R. Hill, Kelli P. A. MacDonald, Victor Tkachev, Takanori Teshima, Stephanie J. Lee, Jerome Ritz, Stefanie Sarantopoulos, Leo Luznik, Defu Zeng, Sophie Paczesny, Paul J. Martin, Steven Z. Pavletic, Kirk R. Schultz, Bruce R. Blazar	11
6	Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Host Disease 2021 ·Blood ·Iskra Pusic, Tanner M. Johanns, Stefanie Sarantopoulos, (unknown), (unknown), Peter Westervelt, Amanda F. Cashen, Geoffrey L. Uy, Camille N. Abboud, John F. DiPersio	1
7	Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells 2021 ·Molecular Cancer Research ·Angel Y.F. Kam, (unknown), Chang‐Lung Lee, David A. Rizzieri, Neil L. Spector, Stefanie Sarantopoulos, Phuong L. Doan	4
8	BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation 2021 ·Blood ·Wei Jia, Jonathan C. Poe, (unknown), Sarah Anand, Glenn K. Matsushima, Jeffrey C. Rathmell, Ivan Maillard, Vedran Radojčić, Kazuhiro Imai, Nancy Reyes, Diana M. Cardona, Zhiguo Li, (unknown), (unknown), (unknown), Daniel R. Saban, Benny J. Chen, Nelson J. Chao, Stefanie Sarantopoulos	20
9	Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality 2020 ·PLoS ONE ·(unknown), Sendhilnathan Ramalingam, Mohammad Rauf Chaudhry, Yi Ren, Sin‐Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis F. Diehl, Cristina Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung	4
10	Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Jeffrey A. Cohen, Laura Baldassari, Harold Atkins, James D. Bowen, Christopher Bredeson, Paul A. Carpenter, John R. Corboy, Mark S. Freedman, Linda M. Griffith, Robert Lowsky, Navneet S. Majhail, Paolo A. Muraro, Richard A. Nash, Marcelo C. Pasquini, Stefanie Sarantopoulos, Bipin N. Savani, Jan Storek, Keith M. Sullivan, George E. Georges	72
11	Biomarkers in chronic graft-versus-host disease: quo vadis? 2018 ·Bone Marrow Transplantation ·Daniel Wolff, Hildegard Greinix, S. J. Lee, Ted Gooley, Sophie Paczesny, Steven Z. Pavletic, Frances T. Hakim, Florent Malard, Madan Jagasia, Ánita Lawitschka, John A. Hansen, Dražen Pulanić, Ernst Holler, Anne M. Dickinson, Eva M. Weissinger, Matthias Edinger, Stefanie Sarantopoulos, Kirk R. Schultz	44
12	Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization 2017 ·Biology of Blood and Marrow Transplantation ·Sarah Anand, Samantha M. Thomas, Terry Hyslop, (unknown), Kelly Corbet, Cristina Gasparetto, Richard D. Lopez, Gwynn D. Long, (unknown), David A. Rizzieri, Keith M. Sullivan, Anthony D. Sung, Stefanie Sarantopoulos, Nelson J. Chao, Mitchell E. Horwitz	27
13	The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease breakdown → 2016 ·Biology of Blood and Marrow Transplantation ·Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia, Daniel H. Fowler, Marcel R.M. van den Brink, John A. Hansen, Robertson Parkman, David B. Miklos, Paul J. Martin, Sophie Paczesny, Georgia B. Vogelsang, Steven Z. Pavletic, Jerome Ritz, Kirk R. Schultz, Bruce R. Blazar	283
14	Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathwayin vivo 2016 ·Nucleic Acids Research ·Yang Yang, Jonathan C. Poe, Lisong Yang, Andrew Fedoriw, (unknown), Terry Magnuson, Zhiguo Li, Yuri Fedoriw, Kimi Araki, Yanzhe Gao, Satoshi Tateishi, Stefanie Sarantopoulos, Cyrus Vaziri	15
15	Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma 2016 ·Biology of Blood and Marrow Transplantation ·Dharshan Sivaraj, Michael Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, Mitchell E. Horwitz, Richard D. Lopez, Keith M. Sullivan, David A. Rizzieri, Nelson J. Chao, Cristina Gasparetto	22
16	National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report 2016 ·Biology of Blood and Marrow Transplantation ·Juan Gea‐Banacloche, Krishna V. Komanduri, Paul A. Carpenter, Sophie Paczesny, Stefanie Sarantopoulos, Jo‐Anne H. Young, Nahed El Kassar, Robert Q. Le, Kirk R. Schultz, Linda M. Griffith, Bipin N. Savani, John R. Wingard	29
17	Bone Marrow B cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development 2012 ·Biology of Blood and Marrow Transplantation ·Yuri Fedoriw, (unknown), Allison M. Deal, Cherie H. Dunphy, (unknown), Thomas C. Shea, Jonathan S. Serody, Stefanie Sarantopoulos	28
18	Qa-1 restriction of CD8+ suppressor T cells 2004 ·Journal of Clinical Investigation ·Stefanie Sarantopoulos, Linrong Lu, Harvey Cantor	114
19	Qa-1 restriction of CD8+ suppressor T cells 2004 ·Journal of Clinical Investigation ·Stefanie Sarantopoulos, Linrong Lu, Harvey Cantor	12
20	Generation of a Polyclonal Fab Phage Display Library to the Human Breast Carcinoma Cell Line BT-20 2000 ·Combinatorial Chemistry & High Throughput Screening ·(unknown), Stefanie Sarantopoulos, (unknown), Svend K. Petersen‐Mahrt, Seshi R. Sompuram, Jacqueline Sharon	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact